BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32880443)

  • 1. Advancements in Assay Technologies and Strategies to Enable Drug Discovery.
    Busby SA; Carbonneau S; Concannon J; Dumelin CE; Lee Y; Numao S; Renaud N; Smith TM; Auld DS
    ACS Chem Biol; 2020 Oct; 15(10):2636-2648. PubMed ID: 32880443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: high-throughput affinity-based technologies for small-molecule drug discovery.
    Zhu Z; Cuozzo J
    J Biomol Screen; 2009 Dec; 14(10):1157-64. PubMed ID: 19822881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Compound Delivery Platforms to Support Miniaturized Biology.
    Bhatt S; Crimmin S; Gross J; Nixon E; Truong M; Weglos M; Kallal L
    SLAS Technol; 2019 Jun; 24(3):245-255. PubMed ID: 30726680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a Microparticle-Based System for Pooled Assays of Small Molecules in Cellular Contexts.
    Yozwiak CE; Hirschhorn T; Stockwell BR
    ACS Chem Biol; 2018 Mar; 13(3):761-771. PubMed ID: 29365249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase biological assays for drug discovery.
    Forsberg EM; Sicard C; Brennan JD
    Annu Rev Anal Chem (Palo Alto Calif); 2014; 7():337-59. PubMed ID: 25000820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of Biophysics in High-Throughput Screening Hit Validation.
    Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
    J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hit Discovery for Public Target Programs in the European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening.
    Honarnejad S; van Boeckel S; van den Hurk H; van Helden S
    SLAS Discov; 2021 Feb; 26(2):192-204. PubMed ID: 32734803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Guide to Run Affinity Screens Using Differential Scanning Fluorimetry and Surface Plasmon Resonance Assays.
    Bergsdorf C; Wright SK
    Methods Enzymol; 2018; 610():135-165. PubMed ID: 30390797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revolution of Small Molecule Drug Discovery by Affinity Selection-Mass Spectrometry Technology.
    Motoyaji T
    Chem Pharm Bull (Tokyo); 2020; 68(3):191-193. PubMed ID: 32115525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encoded Library Technologies as Integrated Lead Finding Platforms for Drug Discovery.
    Ottl J; Leder L; Schaefer JV; Dumelin CE
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31027189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment screening using X-ray crystallography.
    Davies TG; Tickle IJ
    Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow Cytometry: Impact on Early Drug Discovery.
    Edwards BS; Sklar LA
    J Biomol Screen; 2015 Jul; 20(6):689-707. PubMed ID: 25805180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and application of PI3K assays for novel drug discovery.
    Yanamandra M; Mitra S; Giri A
    Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Throughput Phenotypic Screening of Human Astrocytes to Identify Compounds That Protect Against Oxidative Stress.
    Thorne N; Malik N; Shah S; Zhao J; Class B; Aguisanda F; Southall N; Xia M; McKew JC; Rao M; Zheng W
    Stem Cells Transl Med; 2016 May; 5(5):613-27. PubMed ID: 27034412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
    Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
    J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.